Sesen bio, inc. (SESN)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash Flows from Operating Activities:
Cash Flows from Operating Activities:
Net income (loss)

41,564

-33,553

-13,132

-54,335

-6,480

-6,757

-14,015

-8,958

-3,963

-6,547

-9,105

-7,316

-6,061

-3,531

19,487

-6,491

-7,574

-10,329

-9,693

-6,906

-6,524

-8,139

-10,674

-8,121

-7,222

Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation

31

55

57

58

49

52

55

52

49

64

47

92

82

67

18

39

54

74

100

96

96

99

102

108

101

Non-cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

26

41

41

24

2

8

10

10

8

Share-based compensation

407

326

229

356

326

348

249

285

401

562

253

322

244

662

2,144

621

586

634

629

602

664

487

808

501

636

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

0

-

0

-2

-3

-72

64

13

-115

82

-63

-1,819

-1,304

173

0

0

-50

Change in fair value of contingent consideration

-53,700

-

3,600

44,000

-1,000

-

7,200

3,900

-1,200

-

3,900

2,200

1,500

-

0

0

0

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

221

-

-

-

-

-

-

-

-

Gain on sale of equipment

-

-

-

-

-

0

0

0

5

14

15

3

76

10

14

0

0

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Prepaid expenses and other assets

-4,011

4,767

-1,066

-425

1,912

-256

743

190

236

-449

85

73

127

-738

-188

-36

162

-421

-285

441

155

1

-655

849

64

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-15

-55

80

0

0

0

0

-

-

-

-

Accounts payable

166

-681

407

493

316

-24

81

-83

486

-459

121

31

-453

-94

-1,257

267

342

-1,033

399

-163

-415

-671

-14

-179

1,885

Accrued expenses and other liabilities

-1,317

-

800

252

709

-

1,970

-602

85

-

444

236

123

-

-198

654

-1,645

-

641

-611

-598

-

516

683

-215

Deferred revenue

-

-

-

-

-

-

-

-

-

0

0

0

-425

-825

1,250

-203

-203

-65

20

189

-244

-160

-89

-602

-113

Due to related party

-

-

-

-

-

-

-

-

-

-123

5

3

1

-698

0

0

0

-

-

-

-

-

-

-

-

Net Cash Used in Operating Activities

-8,800

-13,821

-6,957

-8,751

-7,992

-7,618

-5,203

-5,596

-4,383

-3,660

-4,435

-4,510

-5,195

-5,600

21,697

-5,009

-8,550

-

-

-

-

-

-

-

-

Net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9,029

-8,478

-7,138

-8,686

-8,449

-5,034

Cash Flows from Investing Activities:
(Purchases) sales of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

254

32

-

5

82

50

Cash Flows from Investing Activities:
(Purchases) sales of equipment

-

-

-

-

-

-

0

0

5

-

15

-7

76

-

-

-

-

-

-

-

-

-

-

-

-

(Purchases) sales of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Net Cash Used in Investing Activities

0

1

-94

-43

0

-7

0

0

5

14

15

-7

76

42

419

0

0

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-254

-32

0

-5

-82

-50

Cash Flows from Financing Activities:
Cash Flows from Financing Activities:
Proceeds from issuance of common stock under ATM Offering, net of issuance costs

3,179

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on equipment financing and notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

14,124

877

0

0

0

3,384

416

417

416

Proceeds from issuance of common stock under ATM Offering, net of issuance costs

-

-

-

-

-

-

-

48,850

9,376

0

0

0

0

-

-

-

-

-25

503

12,218

-46

18,732

0

-2

51,507

Proceeds from exercises of stock options

-

-

-

-

-

-

-

-

-

0

0

0

40

65

116

74

14

1

6

10

46

23

19

17

15

Proceeds from sales of common stock under 2014 ESPP

1

0

1

0

7

-1

11

0

10

0

7

0

5

-

0

0

0

-

-

-

-

-

-

-

-

Net cash (used in) provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17,228

0

25,254

-397

-402

51,106

Net Cash Provided by Financing Activities

3,180

4,060

1

31,288

7

220

98

48,879

9,386

6,953

7

0

45

100

116

74

-14,110

-

-

-

-

-

-

-

-

Net Decrease in Cash, Cash Equivalents and Restricted Cash

-5,658

-9,744

-7,066

22,494

-7,985

-7,434

-5,105

43,283

5,008

3,342

-4,413

-4,517

-5,074

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22,232

-4,935

-22,660

-10,283

-7,132

7,945

-8,510

18,116

-9,088

-8,933

46,022

Supplemental disclosure of non-cash operating activities:
Right-of-use assets related to the adoption of ASC 842

0

0

-236,244

236,244

236

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for amounts included in the measurement of lease liabilities

38

38

-75,956

76,033

38

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosure of non-cash financing activities:
Conversion of Series A and Series B preferred stock into 8,260,444 shares of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

56,678

Conversion of preferred stock warrants into common stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

247

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

663

286

270

199

175

158

54

59

64